Persistent URL of this record https://hdl.handle.net/1887/112999
In Collections
This item can be found in the following collections:
Hypofractionated versus conventionally fractionated radiotherapy for patients with prostate cancer (HYPRO): late toxicity results from a randomised, non-inferiority, phase 3 trial
- All authors
- Aluwini, S.; Pos, F.; Schimmel, E.; Krol, S.; Toorn, P.P. van der; Jager, H. de; Alemayehu, W.G.; Heemsbergen, W.; Heijmen, B.; Incrocci, L.
- Date
- 2016-04-30
- Journal
- The Lancet Oncology
- Volume
- 17
- Issue
- 4
- Pages
- 464 - 474